Alama, A.; Coco, S.; Genova, C.; Rossi, G.; Fontana, V.; Tagliamento, M.; Dal Bello, M.G.; Rosa, A.; Boccardo, S.; Rijavec, E.;
et al. Prognostic Relevance of Circulating Tumor Cells and Circulating Cell-Free DNA Association in Metastatic Non-Small Cell Lung Cancer Treated with Nivolumab. J. Clin. Med. 2019, 8, 1011.
https://doi.org/10.3390/jcm8071011
AMA Style
Alama A, Coco S, Genova C, Rossi G, Fontana V, Tagliamento M, Dal Bello MG, Rosa A, Boccardo S, Rijavec E,
et al. Prognostic Relevance of Circulating Tumor Cells and Circulating Cell-Free DNA Association in Metastatic Non-Small Cell Lung Cancer Treated with Nivolumab. Journal of Clinical Medicine. 2019; 8(7):1011.
https://doi.org/10.3390/jcm8071011
Chicago/Turabian Style
Alama, Angela, Simona Coco, Carlo Genova, Giovanni Rossi, Vincenzo Fontana, Marco Tagliamento, Maria Giovanna Dal Bello, Alessandra Rosa, Simona Boccardo, Erika Rijavec,
and et al. 2019. "Prognostic Relevance of Circulating Tumor Cells and Circulating Cell-Free DNA Association in Metastatic Non-Small Cell Lung Cancer Treated with Nivolumab" Journal of Clinical Medicine 8, no. 7: 1011.
https://doi.org/10.3390/jcm8071011
APA Style
Alama, A., Coco, S., Genova, C., Rossi, G., Fontana, V., Tagliamento, M., Dal Bello, M. G., Rosa, A., Boccardo, S., Rijavec, E., Biello, F., Longo, L., Cavalieri, Z., Bruzzo, C., & Grossi, F.
(2019). Prognostic Relevance of Circulating Tumor Cells and Circulating Cell-Free DNA Association in Metastatic Non-Small Cell Lung Cancer Treated with Nivolumab. Journal of Clinical Medicine, 8(7), 1011.
https://doi.org/10.3390/jcm8071011